The Journal of Biological Regulators and Homeostatic Agents (JBRHA) is a puzzling scientific journal. It published the now-withdrawn bizarre paper on 5G and Coronavirus that caused a lot of commotion (“brouhaha“, meaning commotion or uproar). It is indexed in PubMed, giving it the appearance of a true, National Library of Medicine-approved scientific journal. But the editorial board consists mainly of dead people, the Editor in Chief’s affiliations are unclear, and the content of the journal is mainly empty. We might as well call it the JBRouHAha.
A bizarre paper
As I reported last week, the JBRHA published a widely discussed and now-removed paper claiming that 5G waves can spontaneously generate Coronaviruses in skin cells [retraction notice – archived – PDF]. It was one of the worst papers so far this year, and that is saying something. Because 2020.
What real scientific journal would publish such a bizarre paper? A paper with lots of wild claims, but no data, no proof? Usually, such extraordinary claims are posted on sites like Vixra or predatory publishers because no respectable preprint server or decent scientific journal would even consider to peer review such papers.
In my blog post I already looked a bit into the journal, and I will repeat some of my findings here.
An independent publisher
The JBRHA is published by Biolife, a self-described “independent, academic publisher of innovative, high-quality content” that was founded in 1987. The first JBRHA issue is from a much later date, from January 2006.
Biolife publishers three other journals, but none of them go back older than 2009.
A journal without content
The journal does not appear to have any accessible content. The abstracts of the papers are available in PubMed and on the website of the journal. But for almost all papers, there is no link to a PDF (whether Open Access or behind a paywall). There are no traces of the papers to be found on the internet. And as I mentioned before, you cannot select or copy any text from the website. It is all very bizarre.
It is unclear how anyone can actually access these papers. There is no subscription information. The only option is to order hard copy reprints or ePrints, with a minimum order of 100. Why anyone would want to order 100+ copies of the same PDF is not clear.
Lack of IRB approval or patient consent
Although most JBRHA papers only appear to consist of an abstract, without any means of downloading the PDF, some papers are available as PDFs, and the now-retracted 5G paper also was, albeit briefly.
Unfortunately, those papers appear to have some issues, mainly because they describe studies on patients or patient-derived material without the appropriate statements that the patients gave consent to participate in the study or that the institutional research board (IRB) approved of the study. Some examples:
Candotto V et al. Drug-induced gingival overgrowth: an in vitro study on cyclosporine and human gingival fibroblasts : describes results obtained from tissues taken from three patients, including an 11-year old child, without consent.
Verdoni F et al. Fibula-pro-tibia transfer with external fixator after tibia fracture with extensive bone defect: a case report – describes the medical history of an adult woman referred to as “girl”, listing her age, date of injury, and hospital of treatment. But no word about if she consented to have her case described.
Abbate GM et al. (2016) – Substance P expression in the gingival tissue after upper third molar extraction: effect of ketoprofen, a preliminary study – 20 adults provided informed consent but there is no mention whether an IRB approved the study.
Similar concerns can be raised about other BioLife publications.
The January 2012 issue of the European Journal of Musculoskeletal Diseases has several papers using human subjects that do not mention IRB approval or patient consent (Migliore A. et al, page 15 or Zar VV et al., page 23).
Editorial ghost board
Most journals proudly feature their Editors and affiliations on their website. But the JBRHA Editorial Board appears to be full of Ghosts of Editors Past (a reference to the Ghost of Christmas Past from the Charles Dickens novel A Christmas Carol).
As I wrote previously, several of the listed Editors appear to be deceased, such as S. Pestka, G. Bonadonna, and V. Bocci. But with only the first initial and last name, and no affiliations listed, it is hard to figure out who actually is sitting on the editorial board.
Editor in Chief
Pio Conti is the Editor in Chief of JBRHA. In fact, he appears to be the only person running the journal. If you want to submit a paper, just send him an email and he will personally handle the paper. This is rather unusual for academic journals.
Conti is a professor at the University of Chieti, and although the university does mention him a couple of times in press releases, he does not appear to have a faculty page. He also claims to be an affiliated professor at Tufts University in Boston, although I could not verify this.
Unclear publication fees
It is not clear how much it would cost to publish in the BioLife journals. The “Publication Fees” page does not give any concrete pricing. It has a vague statement saying that “the APC payable for an article is agreed upon during the manuscript submission process” which sounds similar to buying a second hand bicycle or car radio from a drug dealer. The website promises to make the articles visible immediately upon publication, but as I wrote above, this appears to not happen.
With an unclear editorial board consisting of deceased people, one can wonder how much oversight there is in the financial transactions who appear to be handled solely by the Editor in Chief.
Predatory journal or not
The JBRHA journal appears to have many features shared by predatory journals: an unclear / zombie editorial board with no affiliations mentioned, no clear publication fees, no downloadable content, and lack of scientific rigor and ethical requirements. With such questionable practices, it is baffling that the journal is included in PubMed.
Please let me know in the comments below how one can ask PubMed to reconsider indexing JBRHA’s papers.